文献速递血栓与止血贫血与红细胞疾病

遗传性大血小板减少症发病机制研究进展

Advances in understanding the pathogenesis of hereditary macrothrombocytopenia.
PubMed 文献 · Br J Haematol · 2021-03-30

该综述讨论自动化血液分析仪检测血小板计数与体积的解读及大血小板减少症分析的技术考量,总结大型队列对成人血小板参数分布与协变异的描述,以及全基因组关联研究发现的数百个遗传关联和极端表型相关的基因与变异,支持结合基因型与临床及实验室表型的未来诊断策略。

要点

  • 大血小板减少症可为获得性或遗传性,提示复杂疾病。
  • 自动化分析仪测血小板参数需注意大血小板相关技术因素。
  • 全基因组关联研究识别的遗传关联可解释较大比例表型方差。

核心结论

  • 遗传性大血小板减少症发病机制认识已深入,支持基因型联合临床与实验室表型的未来诊断策略。

研究设计与样本

  • 综述,讨论血小板计数与体积的自动化检测解读、大型队列(如UK Biobank和INTERVAL研究)及全基因组关联研究和基因诊断项目。

主要发现

  • 大型队列可准确描述成人血小板参数的分布与协变异。
  • 全基因组关联研究已识别数百个与血小板计数和平均血小板体积相关的遗传关联,聚合可解释较大比例表型方差,符合复杂遗传架构和多基因遗传。
  • 大规模基因诊断与发现项目扩展了与极端血小板表型相关的基因和变异谱。

临床怎么用

  • 临床解读大血小板减少症时需考虑自动化分析仪检测血小板参数的技术因素。
  • 未来诊断可结合基因型与临床及实验室表型数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low platelet count, or thrombocytopenia, is a common haematological abnormality, with a wide differential diagnosis, which may represent a clinically significant underlying pathology. Macrothrombocytopenia, the presence of large platelets in combination with thrombocytopenia, can be acquired or hereditary and indicative of a complex disorder. In this review, we discuss the interpretation of platelet count and volume measured by automated haematology analysers and highlight some important technical considerations relevant to the analysis of blood samples with macrothrombocytopenia. We review how large cohorts, such as the UK Biobank and INTERVAL studies, have enabled an accurate description of the distribution and co-variation of platelet parameters in adult populations. We discuss how genome-wide association studies have identified hundreds of genetic associations with platelet count and mean platelet volume, which in aggregate can explain large fractions of phenotypic variance, consistent with a complex genetic architecture and polygenic inheritance. Finally, we describe the large genetic diagnostic and discovery programmes, which, simultaneously to genome-wide association studies, have expanded the repertoire of genes and variants associated with extreme platelet phenotypes. These have advanced our understanding of the pathogenesis of hereditary macrothrombocytopenia and support a future clinical diagnostic strategy that utilises genotype alongside clinical and laboratory phenotype data.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Collins J, Astle WJ, Megy K, et al. Advances in understanding the pathogenesis of hereditary macrothrombocytopenia. Br J Haematol. 2021. PMID: 33783834. doi:10.1111/bjh.17409

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。